REFERENCES
- Currie G A. Activated macrophages kill tumor cells by releasing arginase. Nature 1978; 273: 758–759
- Matthews N, Neale M L, Jackson S K, et al. Tumor cell killing by tumor necrosis factor: Inhibition by anaerobic conditions, freeradical scavengers and inhibitors or arachidonate metabolism. Immunology 1987; 62: 153–155
- Meltzer M S. Macrophage activation for tumor cytotoxicity: Characterization of priming and trigger signals during lymphokine activation. J Immunol 1981; 127: 179–183
- Fryling C, Dombalagain M, Burgess W, et al. Purification and characterization of tumor inhibitory factor-2: Its identity to inlerleukin 1. Cancer Res 1989; 49: 3333–3337
- Onazaki K, Matushima K, Kleirerman E S, et al. Role of interleukin-1 in promoting human monocyte-mediated tumor cytotoxicity. J Immunol 1985; 135: 314–320
- Chasseing N A, Doria Medina P, Lederkremer R M, et al. Produccion de Interleuquina-I durante el crecimiento tumoral. Medicina (Buenos Aires) 1989; 49: 271–276
- Fruehauf J P, Bonnard G D, Heberman R B. The effect of lentinan on production of interleukin-I human monocytes. Immunopharmacology 1982; 5: 65–74
- Creighton W, Lambert P H, Meischer P A. Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethyleneglycol. J Immunol 1973; 111: 1219–1227
- Herman J, Kew M C, Rabson A R. Defective interleukin-1 production by monocytes from patients with malignant disease. Interferon increases interleukin-1 production. Cancer Immunol Immunother 1984; 16: 182–185
- Ravikumar T, Stell G, Rodrick M, et al. Effects of tumor-growth on interleukins and circulating immune complexes. Cancer 1984; 53: 1373–1378
- Knudsen P J, Dinarello C A, Strom T B. Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin-1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 1986; 137: 3189–3194